raia drogasil s.a. - RADLY

RADLY

Close Chg Chg %
3.84 -0.12 -3.13%

Closed Market

3.72

-0.12 (3.13%)

Volume: 23.47K

Last Updated:

Dec 9, 2024, 3:44 PM EDT

Company Overview: raia drogasil s.a. - RADLY

RADLY Key Data

Open

$3.95

Day Range

3.72 - 4.59

52 Week Range

3.72 - 14.00

Market Cap

$6.79B

Shares Outstanding

1.72B

Public Float

N/A

Beta

0.93

Rev. Per Employee

N/A

P/E Ratio

30.60

EPS

$0.13

Yield

138.82%

Dividend

$0.01

EX-DIVIDEND DATE

Jul 12, 2024

SHORT INTEREST

N/A

AVERAGE VOLUME

26.45K

 

RADLY Performance

1 Week
 
-3.12%
 
1 Month
 
-15.45%
 
3 Months
 
-20.85%
 
1 Year
 
-35.86%
 
5 Years
 
N/A
 

RADLY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 13
Full Ratings ➔

About raia drogasil s.a. - RADLY

Raia Drogasil SA engages in the retail sale of medicine, perfumery, personal care and beauty products, cosmetics and dermocosmetics. Its stores are supplied by distribution centers located in the states of São Paulo, Rio de Janeiro, Minas Gerais, Paraná, Goiás, Pernambuco, and Bahia. The company was founded in 1905 and is headquartered in Butanta, Brazil.

RADLY At a Glance

Raia Drogasil SA
Avenue Corifeu de Azevedo Marques
Butanta, Sao Paulo 05339-000
Phone 55-11-3769-5678 Revenue 6.80B
Industry Drugstore Chains Net Income 211.21M
Sector Retail Trade 2023 Sales Growth 20.849%
Fiscal Year-end 12 / 2024 Employees 57,691
View SEC Filings

RADLY Valuation

P/E Current 30.598
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 48.571
Price to Sales Ratio 1.508
Price to Book Ratio 8.462
Price to Cash Flow Ratio 28.703
Enterprise Value to EBITDA 15.148
Enterprise Value to Sales 1.712
Total Debt to Enterprise Value 0.125

RADLY Efficiency

Revenue/Employee 117,899.195
Income Per Employee 3,661.071
Receivables Turnover 8.575
Total Asset Turnover 1.81

RADLY Liquidity

Current Ratio 1.431
Quick Ratio 0.54
Cash Ratio 0.051

RADLY Profitability

Gross Margin 25.155
Operating Margin 6.412
Pretax Margin 3.618
Net Margin 3.105
Return on Assets 5.62
Return on Equity 18.878
Return on Total Capital 7.878
Return on Invested Capital 9.689

RADLY Capital Structure

Total Debt to Total Equity 118.661
Total Debt to Total Capital 54.267
Total Debt to Total Assets 34.656
Long-Term Debt to Equity 94.097
Long-Term Debt to Total Capital 43.033
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Raia Drogasil S.a. - RADLY

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
3.89B 4.47B 5.63B 6.80B
Sales Growth
-12.63% +14.93% +25.88% +20.85%
Cost of Goods Sold (COGS) incl D&A
2.97B 3.38B 4.21B 5.09B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
222.72M 239.49M 285.28M 332.61M
Depreciation
- - - 204.32M
-
Amortization of Intangibles
- - - 18.40M
-
COGS Growth
-12.41% +13.61% +24.67% +20.98%
Gross Income
919.38M 1.10B 1.42B 1.71B
Gross Income Growth
-13.36% +19.20% +29.61% +20.45%
Gross Profit Margin
+23.63% +24.51% +25.24% +25.15%
2020 2021 2022 2023 5-year trend
SG&A Expense
738.12M 850.03M 1.08B 1.31B
Research & Development
- - - -
-
Other SG&A
738.12M 850.03M 1.08B 1.31B
SGA Growth
-11.11% +15.16% +27.16% +20.97%
Other Operating Expense
2.00M (13.93M) (20.65M) (32.78M)
Unusual Expense
(4.86M) 3.61M 5.49M 12.03M
EBIT after Unusual Expense
184.12M 256.22M 354.71M 424.08M
Non Operating Income/Expense
(5.52M) (14.23M) (19.72M) (37.14M)
Non-Operating Interest Income
1.19M 1.77M 5.48M 10.58M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
57.58M 58.83M 103.79M 140.84M
Interest Expense Growth
-20.61% +2.17% +76.42% +35.69%
Gross Interest Expense
57.58M 58.83M 103.79M 140.84M
Interest Capitalized
- - - -
-
Pretax Income
121.02M 183.16M 231.20M 246.09M
Pretax Income Growth
-39.12% +51.35% +26.22% +6.44%
Pretax Margin
+3.11% +4.10% +4.11% +3.62%
Income Tax
23.43M 41.35M 34.51M 25.94M
Income Tax - Current - Domestic
40.05M 41.00M 40.82M 62.97M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(16.62M) 348.39K (6.31M) (37.03M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
96.07M 141.61M 196.53M 217.65M
Minority Interest Expense
2.15M 2.26M 3.65M 6.44M
Net Income
93.92M 139.35M 192.88M 211.21M
Net Income Growth
-52.02% +48.37% +38.42% +9.51%
Net Margin Growth
+2.41% +3.12% +3.43% +3.11%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
93.92M 139.35M 192.88M 211.21M
Preferred Dividends
- - - -
-
Net Income Available to Common
93.92M 139.35M 192.88M 211.21M
EPS (Basic)
0.0548 0.0812 0.1126 0.1246
EPS (Basic) Growth
-52.06% +48.18% +38.67% +10.66%
Basic Shares Outstanding
1.72B 1.72B 1.71B 1.70B
EPS (Diluted)
0.0546 0.081 0.1121 0.1246
EPS (Diluted) Growth
-52.11% +48.35% +38.40% +11.15%
Diluted Shares Outstanding
1.72B 1.72B 1.72B 1.70B
EBITDA
401.97M 499.32M 645.48M 768.72M
EBITDA Growth
-21.34% +24.22% +29.27% +19.09%
EBITDA Margin
+10.33% +11.17% +11.47% +11.30%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 5.139
Number of Ratings 13 Current Quarters Estimate 0.028
FY Report Date 12 / 2024 Current Year's Estimate 0.118
Last Quarter’s Earnings 0.036 Median PE on CY Estimate N/A
Year Ago Earnings 0.129 Next Fiscal Year Estimate 0.147
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 12 12
Mean Estimate 0.03 0.03 0.12 0.15
High Estimates 0.03 0.03 0.15 0.20
Low Estimate 0.03 0.03 0.11 0.13
Coefficient of Variance 8.32 10.31 10.34 12.27

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 8 7
OVERWEIGHT 0 0 0
HOLD 5 5 5
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Raia Drogasil S.A. in the News